UBC Faculty Research and Publications

Trends in utilization of proton pump inhibitors in British Columbia University of British Columbia. Therapeutics Initiative

Description

Therapeutics Letter 118 investigates trends in utilization of proton pump inhibitors in British Columbia, Canada. Conclusions PPI utilization in British Columbia has risen much faster than population growth. For most indications, PPIs are only recommended for up to 8 weeks duration. In many clinical settings, we do not know whether the benefits of long-term PPI use outweigh the harms. Patients on long-term PPI therapy should be reassessed.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International